[HTML][HTML] Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms
Metastatic colorectal cancer (CRC) with a mismatch repair-deficiency (MMR-
D)/microsatellite instability-high (MSI-H) phenotype carries unique characteristics such as …
D)/microsatellite instability-high (MSI-H) phenotype carries unique characteristics such as …
[HTML][HTML] The prognostic implications of tumor infiltrating lymphocytes in colorectal cancer: a systematic review and meta-analysis
Tumor-infiltrating lymphocytes (TILs) are an important histopathologic feature of colorectal
cancer that confer prognostic information. Previous clinical and epidemiologic studies have …
cancer that confer prognostic information. Previous clinical and epidemiologic studies have …
Landscape of microsatellite instability across 39 cancer types
Purpose Microsatellite instability (MSI) is a pattern of hypermutation that occurs at genomic
microsatellites and is caused by defects in the mismatch repair system. Mismatch repair …
microsatellites and is caused by defects in the mismatch repair system. Mismatch repair …
Mismatch Repair Status and BRAF Mutation Status in Metastatic Colorectal Cancer Patients: A Pooled Analysis of the CAIRO, CAIRO2, COIN, and FOCUS Studies
S Venderbosch, ID Nagtegaal, TS Maughan… - Clinical Cancer …, 2014 - AACR
Purpose: To determine the prevalence and prognostic value of mismatch repair (MMR)
status and its relation to BRAF mutation (BRAF MT) status in metastatic colorectal cancer …
status and its relation to BRAF mutation (BRAF MT) status in metastatic colorectal cancer …
[HTML][HTML] Immunity, inflammation, and cancer
SI Grivennikov, FR Greten, M Karin - Cell, 2010 - cell.com
Inflammatory responses play decisive roles at different stages of tumor development,
including initiation, promotion, malignant conversion, invasion, and metastasis. Inflammation …
including initiation, promotion, malignant conversion, invasion, and metastasis. Inflammation …
Natural innate and adaptive immunity to cancer
The immune system can identify and destroy nascent tumor cells in a process termed cancer
immunosurveillance, which functions as an important defense against cancer. Recently …
immunosurveillance, which functions as an important defense against cancer. Recently …
[HTML][HTML] Recurrent frameshift neoantigen vaccine elicits protective immunity with reduced tumor burden and improved overall survival in a Lynch syndrome mouse …
J Gebert, O Gelincik, M Oezcan-Wahlbrink, JD Marshall… - Gastroenterology, 2021 - Elsevier
Background & Aims DNA mismatch repair deficiency drives microsatellite instability (MSI).
Cells with MSI accumulate numerous frameshift mutations. Frameshift mutations affecting …
Cells with MSI accumulate numerous frameshift mutations. Frameshift mutations affecting …
[HTML][HTML] The shared frameshift mutation landscape of microsatellite-unstable cancers suggests immunoediting during tumor evolution
A Ballhausen, MJ Przybilla, M Jendrusch… - Nature …, 2020 - nature.com
The immune system can recognize and attack cancer cells, especially those with a high load
of mutation-induced neoantigens. Such neoantigens are abundant in DNA mismatch repair …
of mutation-induced neoantigens. Such neoantigens are abundant in DNA mismatch repair …
[HTML][HTML] Immune surveillance of tumors
JB Swann, MJ Smyth - The Journal of clinical investigation, 2007 - Am Soc Clin Investig
The ability of the immune system to identify and destroy nascent tumors, and to thereby
function as a primary defense against cancer, has been debated for many decades. Recent …
function as a primary defense against cancer, has been debated for many decades. Recent …
[HTML][HTML] Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis
Z Mei, Y Liu, C Liu, A Cui, Z Liang, G Wang… - British journal of …, 2014 - nature.com
Background: The role of tumour-infiltrating inflammation in the prognosis of patients with
colorectal cancer (CRC) has not been fully evaluated. The primary objective of our meta …
colorectal cancer (CRC) has not been fully evaluated. The primary objective of our meta …